Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1 (SHIP-1), encoded by the INPP5D gene, is a key negative regulator of the phosphoinositide 3-kinase (PI3K)/Akt signaling pathway, primarily expressed in hematopoietic cells and microglia. By hydrolyzing the 5-phosphate of phosphatidylinositol-3,4,5-trisphosphate (PIP3) to produce phosphatidylinositol-3,4-bisphosphate (PI(3,4)P2), SHIP-1 acts as an enzymatic brake on immune cell activation, proliferation, and survival. In the central nervous system, SHIP-1 inhibits TREM2/DAP12 signaling in microglia, thereby restricting neuroprotective microglial responses such as phagocytosis and amyloid-beta clearance. Consequently, SHIP-1 has emerged as a major therapeutic target in late-onset Alzheimer's disease, where small-molecule inhibitors are being developed to boost microglial clearance of plaques. Conversely, SHIP-1 activators, such as the clinical-stage candidate rosiptor (AQX-1125), have been investigated for their anti-inflammatory properties in treating inflammatory and autoimmune diseases by dampening overactive PI3K signaling.
Allosteric activation of SHIP-1 to enhance its phosphatase activity and suppress PI3K/Akt signaling, or competitive inhibition of SHIP-1 to block its phosphatase activity, thereby enhancing TREM2 signaling and microglial phagocytosis.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1 (SHIP-1).